GlyCardial

Act before it’s too late

The AGLYC project is about developing a new diagnostic test based on the quantification of specific protein modifications as a novel and disruptive approach to detect cardiac ischemia.

The AGLYC Project

A GlyCardial Diagnostics’ Project

100%

Production of AGLYC Reagents

60%

Clinical Validation of AGLYC

60%

Business Relevant Activities & IP Protection

66%

Project Management

55%

Communication and Dissemination

70%

Regulatory Activities

Whole project

70%